1. |
Kasa P, Papp H, Kasa P Jr, et al. Donepezil dose-dependently inhibits acetylcholinesterase activity in various areas and in the presynaptic cholinergic and the postsynaptic cholinoceptive enzyme-positive structures in the human and rat brain[J]. Neuroscience, 2000, 101(1): 89-100.
|
2. |
徐學君, 徐德琴, 汪駿. 多奈哌齊的藥理作用及其臨床應用研究進展[J]. 安徽醫藥, 2009, 13(4): 352-354.
|
3. |
黃立志, 付葉水, 李毅. 鹽酸多奈哌齊治療老年癡呆療效觀察[J]. 中國社區醫師(醫學專業), 2011, 13(271): 124-125.
|
4. |
張媛媛, 蘇忠亮, 呂英濤, 等. 鹽酸多奈哌齊口腔崩解片的制備及質量控制[J]. 中國現代應用藥學雜志, 2009, 26(83): 2041-2043.
|
5. |
Yasui-Furukori N, Furuya R, Takahata T, et al. Determination of donepezil, an acetylcholinesterase inhibitor, in human plasma by high-performance liquid chromatography with ultraviolet absorbance detection[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2002, 786(2): 261-265.
|
6. |
Koeber R, Kluenemann HH, Waimer R, et al. Implementation of a cost-effective HPLC/UV-approach for medical routine quantification of donepezil in human serum[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2012, 881-882: 1-11.
|
7. |
Apostolou C, Dotsikas Y, Kousoulos C, et al. Quantitative determination of donepezil in human plasma by liquid chromatography/tandem mass spectrometry employing an automated liquid–liquid extraction based on 96-well format plates: Application to a bioequivalence study[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2007, 848(2): 239-244.
|
8. |
胡錦芳, 程曉華, 熊玉卿. HPLC-ESI-MS測定人血漿中多奈哌齊的濃度[J]. 中國醫院藥學雜志, 2008, 28(23): 670-673.
|
9. |
郝歆愚, 丁黎, 李麗敏, 等. 鹽酸多奈哌齊膠囊及片劑的人體生物等效性研究[J]. 藥學學報, 2003, 38(5): 392-934.
|
10. |
董瑞謙, 王本杰, 郭瑞臣. 鹽酸多奈哌齊片人體生物等效性研究[J]. 中國現代應用藥學雜志, 2004, 8(21): 293-295.
|
11. |
胡錦芳, 程曉華, 熊玉卿. 鹽酸多奈哌齊分散片在健康人體的生物等效性研究[J]. 第二軍醫大學學報, 2009, 30(2): 224-226.
|
12. |
陸益紅, 文紅梅, 李偉, 等. 國產與進口鹽酸多奈哌齊片在健康人體的生物等效性[J]. 中國臨床藥理學雜志, 2010, 26(3): 201-204.
|
13. |
宋薇, 楊靜, 馮智軍, 等. 鹽酸多奈哌齊口腔崩解片人體生物等效性研究[J]. 中國藥師, 2012, 15(3): 334-337.
|